Viemed Healthcare, Inc.
VMD
$9.65
$0.020.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.10% | 20.52% | 18.90% | 17.11% | 19.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.10% | 20.52% | 18.90% | 17.11% | 19.97% |
| Cost of Revenue | 26.48% | 26.10% | 26.05% | 24.94% | 27.36% |
| Gross Profit | 20.72% | 16.71% | 14.18% | 12.09% | 15.26% |
| SG&A Expenses | 16.51% | 15.39% | 15.71% | 14.84% | 18.56% |
| Depreciation & Amortization | 7.70% | 0.13% | -8.45% | -15.38% | -9.58% |
| Other Operating Expenses | 87.35% | 84.51% | -92.33% | -273.28% | -3,797.67% |
| Total Operating Expenses | 21.32% | 20.55% | 19.67% | 18.38% | 21.05% |
| Operating Income | 45.44% | 20.22% | 10.18% | 2.93% | 7.90% |
| Income Before Tax | 24.76% | 34.61% | 34.29% | 49.32% | 22.20% |
| Income Tax Expenses | 29.30% | 34.24% | 35.77% | 46.02% | 24.73% |
| Earnings from Continuing Operations | 22.87% | 34.77% | 33.66% | 50.79% | 21.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -113.10% | -206.94% | -936.11% | -3,377.78% | -- |
| Net Income | 21.19% | 32.57% | 30.55% | 47.63% | 18.96% |
| EBIT | 45.44% | 20.22% | 10.18% | 2.93% | 7.90% |
| EBITDA | 27.36% | 15.89% | 10.06% | 5.51% | 9.08% |
| EPS Basic | 22.71% | 33.18% | 29.22% | 45.44% | 17.29% |
| Normalized Basic EPS | 54.49% | 23.98% | 12.26% | 5.35% | -6.42% |
| EPS Diluted | 21.10% | 29.57% | 31.42% | 52.92% | 22.49% |
| Normalized Diluted EPS | 55.04% | 24.42% | 11.94% | 5.02% | -6.60% |
| Average Basic Shares Outstanding | -0.99% | 0.10% | 1.10% | 1.53% | 1.41% |
| Average Diluted Shares Outstanding | -1.37% | -0.04% | 1.50% | 1.90% | 1.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |